Latest / Pharmacy Podcast Network / New Partnership Empowering Independent Pharmacy & GLP-1 Marketing | TWIRx
Transcript
- 0:18Speaker 1: This week in pharmacy, I have a panel that we're
- 0:21Speaker 1: bringing in because of the excitement that we found during
- 0:25Speaker 1: a press release that was just came out in February
- 0:29Speaker 1: and of February mid February, February sixteenth, the press release
- 0:33Speaker 1: read Independent Pharmacy Cooperative and Legacy Pharmacy Group announced a
- 0:38Speaker 1: strategic cooperation agreement. And someone who pays a lot of
- 0:43Speaker 1: attention to how these types of partnerships impact our independent
- 0:48Speaker 1: community pharmacies throughout the country, I was very interested in
- 0:52Speaker 1: learning more about this partnership and I'm very excited to
- 0:55Speaker 1: have today the CEO of the Legacy Pharmacy Group, To Shaw,
- 1:01Speaker 1: the CEO of IPC, Marc Asenza, and our government relations
- 1:05Speaker 1: lead at IPC, Mark Kinney.
- 1:08Speaker 2: Welcome to Torks guys.
- 1:10Speaker 3: Thank you, good morning, good morning.
- 1:12Speaker 4: To be on.
- 1:15Speaker 1: So I'm not going to make any of you twerks
- 1:17Speaker 1: unless you really really really want to. We're here today
- 1:21Speaker 1: speaking about the importance of this. We're going through some
- 1:25Speaker 1: major changes in our profession the last two years, I
- 1:30Speaker 1: would say, twenty twenty three, twenty four or a lot
- 1:33Speaker 1: of black eyes on our independent community pharmacies. But something
- 1:38Speaker 1: that I'm sensing is a resurgence in strength and positioning
- 1:43Speaker 1: with regards to some of our high performing pharmacies, and
- 1:47Speaker 1: it's giving a lot of lesson in mastermind like direction
- 1:51Speaker 1: to other community pharmacies to say, hey, we have to
- 1:54Speaker 1: start changing our business models in ways in order to
- 1:58Speaker 1: keep up with these changing times and really not standing
- 2:01Speaker 1: or waiting around for PBM reform to be perfect. And
- 2:06Speaker 1: I'm a glass half full kind of guy. I don't
- 2:08Speaker 1: think it will ever be perfect. But these kinds of
- 2:11Speaker 1: partnerships are key. RATSH tell us about your organization and
- 2:16Speaker 1: why the joining forces with IPC is so important.
- 2:21Speaker 5: Todd, thank you so much. We are super excited to
- 2:25Speaker 5: have this partnership with IPC, which needs no introduction in
- 2:30Speaker 5: this pharma space. But I'm a pharmacist by trade married
- 2:35Speaker 5: to a pharmacist for together. I always use that to
- 2:39Speaker 5: get better discount because people get excited.
- 2:41Speaker 3: But as a pharmacist.
- 2:43Speaker 5: Own GPO, we are in this space for more than
- 2:46Speaker 5: ten years and having about seven hundred plus pharmacies in
- 2:50Speaker 5: about sixteen plus states of our presence, So for me, more
- 2:56Speaker 5: is about pharmacy pharmacists, the otel pharmacist and how do
- 3:00Speaker 5: we do it? And in the world of the PBMs
- 3:05Speaker 5: and how pharmacists has been treated. We did not think twice,
- 3:11Speaker 5: how do we strategize to work with IPC as they
- 3:15Speaker 5: are they have unique position in market space and our
- 3:19Speaker 5: strategy partnership with IPC, with our actually with our magazine
- 3:23Speaker 5: customers not only brings so only you know, we often
- 3:27Speaker 5: talk about the cost of goods, but also so many
- 3:30Speaker 5: other avenues that I am personally interested as a as
- 3:34Speaker 5: a pharmacist and CEO that what they do and what
- 3:37Speaker 5: they bring on so I can bring that to our
- 3:40Speaker 5: legacy pharmacy group members and one of the unique stuff
- 3:44Speaker 5: that they are doing it I care and I'm super
- 3:46Speaker 5: duper excited about bringing that awareness for patients, which is
- 3:51Speaker 5: a center focal point as we are committed you know
- 3:56Speaker 5: this for our patients and that's how my GPU has
- 3:59Speaker 5: been growing as one of the fastest green GPO in
- 4:02Speaker 5: Anchol site. So I'm super excited to partner with IPC
- 4:07Speaker 5: and Mark and his vision to bring this relationship in
- 4:10Speaker 5: a next level.
- 4:11Speaker 1: Thank you, no, thank you, Protesha. I appreciate that. Mark,
- 4:15Speaker 1: welcome back to twerks. It's great to see you. It's
- 4:18Speaker 1: great to have you back. You have a quote out
- 4:20Speaker 1: on this press release and it says this partnership is
- 4:23Speaker 1: a big step for IPC in LPG community pharmacies. This
- 4:26Speaker 1: collaboration creates new opportunities to grow, improve patient care, and
- 4:30Speaker 1: strengthen the future of community pharmacy. Together, we're building a
- 4:34Speaker 1: more resilient and innovative healthcare system. I want you to
- 4:38Speaker 1: elaborate on that, because when I read that statement, I
- 4:41Speaker 1: knew coming from you. You don't say stuff unless you
- 4:44Speaker 1: really mean it. I've talked to you in so many
- 4:47Speaker 1: round circles, and the wisdom that you give out it's
- 4:52Speaker 1: not as often as me, who talks all the time,
- 4:55Speaker 1: but when you give it, I pay attention. So tell
- 4:57Speaker 1: us about the strategic partnership with LPG.
- 5:01Speaker 3: Now.
- 5:01Speaker 6: We're certainly excited with Ratash and Legacy to be strategically
- 5:06Speaker 6: religned in terms of moving community pharmacy forward here in
- 5:11Speaker 6: the US. One of the things that we've been working on,
- 5:13Speaker 6: and we've talked about this in the past, is our
- 5:17Speaker 6: table stakes as an industry through NCPA, through the work
- 5:21Speaker 6: that we're doing government affairs, is PBM reform, getting fair reimbursement,
- 5:25Speaker 6: going towards provider status. Those are table stakes for where
- 5:29Speaker 6: it is today. But even if and to your point earlier,
- 5:33Speaker 6: it has being a glass half full, the reimbursement and
- 5:37Speaker 6: the cost of good side is not going to sustain
- 5:41Speaker 6: community pharmacy along into the future. So what we've been
- 5:44Speaker 6: endeavoring to do in partnerships such as Legacy and our
- 5:47Speaker 6: friends that Aspire is a matter of how do we
- 5:49Speaker 6: get community pharmacies, as we call in future future ready,
- 5:55Speaker 6: such that, as we learned during the COVID pandemic, community
- 5:59Speaker 6: pharmacy is as much a part of the healthcare infrastructure
- 6:03Speaker 6: of America as any other hospital provider practice those types
- 6:09Speaker 6: of things, and if anything, it's the lowest cost, most
- 6:11Speaker 6: successible entrance into the health space. So what we're trying
- 6:18Speaker 6: to do is to take that infrastructure, take that haliable
- 6:20Speaker 6: effect we had from the pandemic where we were really
- 6:23Speaker 6: helpful to the nation and people started to realize how
- 6:27Speaker 6: important it is that we are to the infrastructure and
- 6:30Speaker 6: building these tools such that community pharmacy through our digital
- 6:33Speaker 6: health platform can have access to teledoc services, remote patient monitoring,
- 6:40Speaker 6: point of care testing, and then even taking a step
- 6:44Speaker 6: further where we actually have clinics within our digital health
- 6:48Speaker 6: atmosphere such as we have a weight loss clinic where
- 6:51Speaker 6: you can access a doctor, you can access the prescriptions
- 6:57Speaker 6: as well as the services that you need just open
- 6:59Speaker 6: a bove the prescription in of itself. So it's a
- 7:02Speaker 6: matter of going back adding that capability of community pharmacy
- 7:08Speaker 6: and then going to your planned sponsors, going to brand manufacturers,
- 7:13Speaker 6: going to even PBMs or the wholesalers. Where we have
- 7:17Speaker 6: these capabilities, we are the lowest cost of serve environment,
- 7:22Speaker 6: and this is where we can start to add savings
- 7:25Speaker 6: and synergies within the within the market space in order
- 7:29Speaker 6: to deliver health care better, make community pharmacies sustainable, and
- 7:33Speaker 6: make them as much part of the care continuum and
- 7:36Speaker 6: the care team as our vision you know suggests. So
- 7:39Speaker 6: we're very excited obviously with the legacy joining us UH
- 7:44Speaker 6: for with us to be able to access these types
- 7:46Speaker 6: of tools, be able to future proof and future ready
- 7:48Speaker 6: independent pharmacy, and quite honestly, to continue to grow our
- 7:51Speaker 6: network in order to have that heat map coverage for
- 7:55Speaker 6: patients in both rural and urban settings that we can
- 7:59Speaker 6: start to deliver these things that we've been building.
- 8:03Speaker 1: The public is finally realizing the importance of pharmacy based
- 8:07Speaker 1: on the coverage that our big media outsource groups are
- 8:12Speaker 1: putting out there. Just this week in Pharmacy, San Francisco
- 8:17Speaker 1: leaders explore options as pharmacy struggle to stay open. This
- 8:21Speaker 1: is from CBS News and it comes out of the
- 8:24Speaker 1: Bay Area, specific to the struggles that the San Francisco
- 8:28Speaker 1: areas having with pharmacy coverage.
- 8:31Speaker 2: That's not news to us, for we know this, we
- 8:34Speaker 2: live this.
- 8:34Speaker 1: We know that the decline started about five years ago
- 8:38Speaker 1: and there was going to be issues based on the
- 8:41Speaker 1: rise of the gluttonous profiteering big three PBMs, and everyone
- 8:49Speaker 1: in the space started making adjustments. And what those adjustments
- 8:52Speaker 1: meant meant that you were going to start building relationships
- 8:57Speaker 1: with politicians throughout the nation and people like Mark McKinney
- 9:01Speaker 1: are key to that. And these two organizations have been
- 9:05Speaker 1: working together on an advocacy for independent pharmacies. With this
- 9:09Speaker 1: partnership to make it even stronger moving forward, these two
- 9:12Speaker 1: groups together and everyone can agree that we need a
- 9:16Speaker 1: seat at the table, a voice at the table, and
- 9:20Speaker 1: we're excited to have the four of you speaking. I
- 9:23Speaker 1: do want to shift it to Mark McKinney just to
- 9:26Speaker 1: give us an opening and overview on some of the
- 9:28Speaker 1: things that you'll be working on together, specifically in the
- 9:31Speaker 1: great state of New York and New Jersey.
- 9:34Speaker 3: Yeah, Todd, thank you for that.
- 9:36Speaker 7: No one's more excited about this partnership than I am,
- 9:40Speaker 7: only because we've had a great relationship in the government
- 9:44Speaker 7: relations arena for quite some years now and we've worked
- 9:48Speaker 7: with Riteesh and Legacy Group and been able to accomplish
- 9:53Speaker 7: I think some really good good outcomes with that and.
- 9:58Speaker 3: Legacy grew. They do it the right way.
- 10:02Speaker 7: You know, they invest the resources, they help boots on
- 10:07Speaker 7: the ground, they have relationships with their elected officials, and
- 10:12Speaker 7: you know, it's not the easy way, but it's the
- 10:15Speaker 7: right way. And because of that, I think they've enjoyed
- 10:18Speaker 7: some success. And I'm really excited about you. While we've
- 10:22Speaker 7: worked with them in the past, I think as you indicated, Todd,
- 10:27Speaker 7: is that you know it'll be a bigger voice, a
- 10:32Speaker 7: stronger voice out there as we partner and work together
- 10:36Speaker 7: in the future.
- 10:38Speaker 1: You also mentioned New Jersey. One of the biggest things
- 10:41Speaker 1: that you're working on members of the New Jersey Independent
- 10:44Speaker 1: Pharmacy Coalition is a bill that started last year that
- 10:48Speaker 1: would require Medicaid Managed care reform to become transparent and
- 10:54Speaker 1: can you kind of expand upon that mark and how
- 10:57Speaker 1: that's going to be positioned and work.
- 11:00Speaker 7: Yeah, I mean we've been working with this in different
- 11:03Speaker 7: states as well, but Medicaid management reform is important to
- 11:08Speaker 7: make sure that the reimbursement rates are are objective and
- 11:12Speaker 7: transparent in a particular state medicaid program, and right now
- 11:18Speaker 7: it's under managed care. Many times it's opaque, not transparent.
- 11:23Speaker 7: So it's good for the patients, it's good for the government,
- 11:28Speaker 7: and it's good for the pharmacies. I would like to
- 11:32Speaker 7: stop at the New York issue again. In the you
- 11:36Speaker 7: know there, we're doing a commercial floor bill, that's what's
- 11:41Speaker 7: set a commercial floor reimbursement that is really new, but
- 11:46Speaker 7: it's happening across the country and.
- 11:48Speaker 3: We're really excited about that.
- 11:50Speaker 7: And then also a test and Treat bill which will
- 11:53Speaker 7: bring in hopefully have passed, new revenues for our independent
- 11:58Speaker 7: pharmacy members. And that's one of the things I think,
- 12:01Speaker 7: you know, rotation and I what we what we see
- 12:04Speaker 7: as you know, government relations can be a vehicle for
- 12:10Speaker 7: bringing in new revenue sources and expanding the scope of
- 12:13Speaker 7: pharmacy services and really providing some support for our member pharmacies.
- 12:20Speaker 1: So when you think of the heat that is finally
- 12:24Speaker 1: being put on the PBMs, now is the time to
- 12:28Speaker 1: engage those state representatives. Mark gives some coaching to our
- 12:32Speaker 1: listeners who are pharmacy owners out there, kind of an
- 12:37Speaker 1: in engaging their their state representatives and bringing them into
- 12:42Speaker 1: the pharmacy, touring them and describing the benefit and the
- 12:46Speaker 1: value that they present to their communities.
- 12:49Speaker 3: Yeah, Tod, that's spot on.
- 12:51Speaker 7: The number one thing that our member pharmacies can do
- 12:56Speaker 7: is get to know they're elected official, invite them into
- 12:59Speaker 7: the pharmacy, see how they interact with those patients, and
- 13:05Speaker 7: that has been a game changer when that happens. The
- 13:09Speaker 7: other thing that we do is, you know, with our grassroots,
- 13:13Speaker 7: we notify our members to reach out on specific legislation
- 13:18Speaker 7: and talk to their elected officials about that. What we've
- 13:21Speaker 7: found here recently is that we're getting a much bigger
- 13:24Speaker 7: uptech on responses to that, and I think a lot
- 13:29Speaker 7: of pharmacies. One they're very busy, so understand that. But
- 13:34Speaker 7: two it's kind of a maybe a scary process if
- 13:37Speaker 7: you've never done it before, and we try to make it.
- 13:40Speaker 3: As easy as possible.
- 13:42Speaker 7: And the pharmacists that have now done this. You know,
- 13:47Speaker 7: the response back was, boy, that was that was easier
- 13:50Speaker 7: than I thought it was going to be. So now
- 13:52Speaker 7: the good news is that, you know, we're getting more
- 13:54Speaker 7: and more responses back.
- 13:56Speaker 3: That in fact, they have reached out and we can
- 13:58Speaker 3: track that and.
- 14:00Speaker 7: And I think especially in the States, pharmacies are seeing
- 14:05Speaker 7: the fruit of that labor because we're passing some really
- 14:07Speaker 7: good legislation.
- 14:09Speaker 1: Ratasha, it's not your first rodeo. You know exactly how
- 14:13Speaker 1: to do this kind of explain some of the success
- 14:15Speaker 1: stories that you've had in engaging our state representatives to
- 14:18Speaker 1: really educate them.
- 14:20Speaker 5: You know what I learned, and I'll share a small
- 14:23Speaker 5: old story when I put my food into the understanding
- 14:27Speaker 5: how politicians, the legislators and the elected officials can make
- 14:32Speaker 5: a difference in its time. They are constantly worried about
- 14:37Speaker 5: two things. One is money and the second one is votes.
- 14:41Speaker 5: And we all know this. So what I've been doing
- 14:46Speaker 5: it for more than decades now, educating it. And I
- 14:50Speaker 5: was able to build up this relationship for so many
- 14:52Speaker 5: years now, and now I have so many legislators on
- 14:57Speaker 5: my cell phone and when they're on the floor they'll
- 14:58Speaker 5: be texting with test should yes or no on this bill?
- 15:02Speaker 5: That kind of relationship and we have a true champion,
- 15:05Speaker 5: Centator Wing go Pala now is a Senate measur y
- 15:09Speaker 5: whip who has been helping us single handedly with so
- 15:14Speaker 5: many great legislators here in New Jersey, including Senate President
- 15:19Speaker 5: and Assembly Speaker Senator Raj Mukerjee, who understand and who've
- 15:24Speaker 5: been on the forefront of this and how marks it
- 15:30Speaker 5: you know currently what is happening in twenty twenty five
- 15:33Speaker 5: that Medicaid managed care and also fee for services which
- 15:38Speaker 5: has been a huge focal point for us, and we
- 15:41Speaker 5: want to make sure we can get that accomplished. And
- 15:44Speaker 5: I have commitment from those legislators to have that on
- 15:47Speaker 5: a governor's desk to be get signed. And as a
- 15:51Speaker 5: matter of fact, I'm going to be meeting us six
- 15:54Speaker 5: legislators tonight at six thirty right here in Eaton Town
- 15:58Speaker 5: and go pal Assembly and Stanley Shirley Assemblyman who's just entered,
- 16:04Speaker 5: and two Congressmen, Herb Conway who just became District six
- 16:08Speaker 5: congressmen in a House of Representative he took a seat. Well,
- 16:12Speaker 5: when they're saying uh ka, Indian American to be elected
- 16:16Speaker 5: in Assembly. Uh, so I'm going to be there. I'm
- 16:19Speaker 5: hosting them and uh, this is what we're gonna as
- 16:23Speaker 5: we talk more about because they know they need us
- 16:26Speaker 5: New Jersey. You know, we are at about seven one
- 16:29Speaker 5: hundred and change community pharmacies left and they know how
- 16:33Speaker 5: we work closely for better patient access and this is
- 16:37Speaker 5: the key point. And they know if we are taken
- 16:40Speaker 5: out from these equations, New Jersey would not have that
- 16:43Speaker 5: health care that they need.
- 16:46Speaker 4: We have proven as.
- 16:47Speaker 5: A community pharmacy owners during pandemic when Governor needed us
- 16:53Speaker 5: as a legacy, as I as a pharmacist, we deployed
- 16:56Speaker 5: those pharmacists to be there to do COVID specimen collection
- 17:01Speaker 5: and to sow and vaccinations. We were the first one
- 17:06Speaker 5: we got on record with the Board of Pharmacy to
- 17:08Speaker 5: do this. And legislators understand I'm the phase for my
- 17:11Speaker 5: community pharmacy owners and they know we are struggling. But
- 17:16Speaker 5: having IPC now, I remember John Cavallo who came with
- 17:20Speaker 5: the check to support Senator Gopal and I said, hey, Novitesh,
- 17:25Speaker 5: we are in this together. So having organization under leadership
- 17:29Speaker 5: of Mark at IPC as this support so many states,
- 17:33Speaker 5: but supporting New Jersey is very important. And uh, we
- 17:37Speaker 5: are happy with this great partnership that you know what,
- 17:41Speaker 5: I see light at the end of the tunnel. There's
- 17:43Speaker 5: a lot of work needs to be done. But listen,
- 17:45Speaker 5: it's not one two three, it's not a transactional. We
- 17:49Speaker 5: need to be constantly at it to make this happen,
- 17:52Speaker 5: and uh, you know what, we'll get some results.
- 17:57Speaker 3: I'm committed to.
- 17:58Speaker 5: So that's what I have what two cents on this?
- 18:02Speaker 1: Well, that's exciting something that you said, Mark, and I
- 18:04Speaker 1: want to bring this back up for our listeners as
- 18:07Speaker 1: you and we can't get into it today. We don't
- 18:09Speaker 1: have enough time. I'll bring Ashton back to dig in.
- 18:12Speaker 1: But the I Care Plus platform is a game changer.
- 18:17Speaker 1: And if you're listening right now and you don't know
- 18:19Speaker 1: about this, you can google I Care Plus. Like the
- 18:23Speaker 1: plus sign IPC, it comes right up on Google. And
- 18:27Speaker 1: we have had several episodes about that. I'm going to
- 18:30Speaker 1: make an assumption, Mark, and I'll kick it back to
- 18:33Speaker 1: you to follow up on the assumption. And that is
- 18:36Speaker 1: now we can take all of the pharmacies in this
- 18:39Speaker 1: partnership and give them access to becoming tech digital health
- 18:45Speaker 1: empowered through the I Care plus system.
- 18:47Speaker 2: Is that true?
- 18:49Speaker 4: Yeah, you're exactly right.
- 18:50Speaker 6: So you become a virtual healthcare center once we've installed
- 18:55Speaker 6: installed the program at each of these pharmacies, and then
- 18:58Speaker 6: they'll have access to all the tools and items that
- 19:04Speaker 6: we can use in terms of being able to get
- 19:06Speaker 6: patient access, being able to serve their communities, and being
- 19:09Speaker 6: able to partner with the providers in there, either in
- 19:14Speaker 6: their community or with the providers that we have on
- 19:16Speaker 6: the platform. So we're very excited about getting as many
- 19:19Speaker 6: of the stores access to this. The whole platform is
- 19:24Speaker 6: pharmacy centric, so typically EMRs are centric around either a
- 19:30Speaker 6: primary care provider or a hospital system. This one year
- 19:32Speaker 6: is very pharmacy centric. So being able to be as
- 19:36Speaker 6: much a part of the care team and almost the
- 19:38Speaker 6: quarterback and some of these things with the first interaction
- 19:41Speaker 6: with the patient is going to be very important now
- 19:43Speaker 6: and into the future, and as we look at.
- 19:47Speaker 3: Ways to.
- 19:49Speaker 6: Look at savings within the overall healthcare system, being able
- 19:53Speaker 6: to move patients or serve patients with the lowest cost
- 19:57Speaker 6: settings in the future is going to be important for
- 20:00Speaker 6: the nation to be able to bring down overall costs
- 20:03Speaker 6: without harming patient access or benefits, which is you know,
- 20:07Speaker 6: one of the mautras of both parties is to is
- 20:10Speaker 6: to not not to damage any of these benefits, but
- 20:13Speaker 6: certainly it is to deliver it in a more cost
- 20:17Speaker 6: effective as well as well of clinically effective solutions. So
- 20:21Speaker 6: we're excited about getting our members access to that, and
- 20:23Speaker 6: certainly legacy members now have access to the setup program
- 20:27Speaker 6: and being able to get set up.
- 20:30Speaker 2: That's terrific.
- 20:31Speaker 1: We are also excited about that announcement and the technology
- 20:35Speaker 1: and the platform. We will be doing more additional coverage
- 20:38Speaker 1: on I Care Plus. If you're curious once again, you
- 20:42Speaker 1: can go to my I Care Plus. That's my letter,
- 20:47Speaker 1: I Care p l us dot com, my Care my
- 20:51Speaker 1: care Plus, my i Care plus dot com. And so
- 20:56Speaker 1: we'll be seeing the team, the IPC team at Idea
- 21:02Speaker 1: Share this coming summer.
- 21:04Speaker 2: Ratesh, you'll be.
- 21:05Speaker 1: There, right, We'll be there, Yes, absolutely, We're going to
- 21:07Speaker 1: be doing some shows there.
- 21:09Speaker 2: We're going to have a lot of guest hosts.
- 21:11Speaker 1: Ratesh will have to assign you to a subject and
- 21:14Speaker 1: get you talking about it and pulling in some members.
- 21:16Speaker 2: It would be wonderful.
- 21:18Speaker 8: Mark.
- 21:19Speaker 1: We have to do a follow up on the PBM
- 21:21Speaker 1: Reform podcast and get some updates from a national and
- 21:24Speaker 1: a state perspective.
- 21:26Speaker 2: We're always appreciate your insights.
- 21:29Speaker 1: Mark, it was so exciting to work with the team
- 21:31Speaker 1: at the Atrium X conference that went really well, Mastermind
- 21:34Speaker 1: conference that was very novel and new, and we're looking
- 21:38Speaker 1: forward to working with IPC and other national conferences as well.
- 21:42Speaker 2: Mark excellent.
- 21:44Speaker 6: Well, thank you for all you do for independent pharmacy,
- 21:46Speaker 6: getting the word out, spreading the knowledge to independent pharmacists,
- 21:49Speaker 6: legislators and anybody else within this ecosphere. So thank you
- 21:53Speaker 6: for what you do as well on a weekend and
- 21:56Speaker 6: week out basis.
- 21:57Speaker 1: Absolutely Hey listeners, we're going to take a quick break
- 22:00Speaker 1: and we'll be right back. You're listening to this Week
- 22:03Speaker 1: in Pharmacy.
- 22:12Speaker 9: This episode is sponsored by Independent Pharmacy Cooperative, widely known
- 22:16Speaker 9: as IPC. Established in nineteen eighty three, IPC is the
- 22:20Speaker 9: nation's largest group purchasing organization owned by independent Pharmacy with
- 22:24Speaker 9: a mission of maximizing the success.
- 22:26Speaker 8: Of community pharmacists.
- 22:28Speaker 9: IPC works to provide members with access to effective programs
- 22:32Speaker 9: and services designed to enhance profitability for independent pharmacy. Read
- 22:36Speaker 9: more about our mission by checking out our website at
- 22:39Speaker 9: ipcarx dot com. That's ipcarx dot com.
- 22:54Speaker 1: Hey, welcome back to this Week in Pharmacy. This is
- 22:58Speaker 1: an interesting next segment because there's two guys that I've
- 23:02Speaker 1: known for quite some time.
- 23:04Speaker 2: It's making me feel old that started.
- 23:07Speaker 1: Commenting on a LinkedIn post and it was initially crafted
- 23:12Speaker 1: by the one and only doctor Joey Maddingley, who is
- 23:18Speaker 1: one of my PBM heroes. And what he had to
- 23:21Speaker 1: say in the last time we had him on Twerks,
- 23:23Speaker 1: but he he commented on the whole GLP one compound
- 23:29Speaker 1: distribution branded not branded? What are your partners and pharmacy contracts?
- 23:36Speaker 1: And I love the post. I love the comments that
- 23:38Speaker 1: were coming from Darshawn cool Carney, who's no stranger to
- 23:42Speaker 1: the Pharmacy podcast land. I'm so excited to have you
- 23:46Speaker 1: both today. Welcome to Twerks and.
- 23:49Speaker 2: I'm going to works. Unless you guys want to to work,
- 23:51Speaker 2: you could get up do something.
- 23:55Speaker 8: I mean, I'm here with the podfather and mister Maddingley
- 23:59Speaker 8: like I'm not worthy. So you know, for those people
- 24:02Speaker 8: who don't get it, that's from what was the show
- 24:05Speaker 8: from Siuran night.
- 24:06Speaker 1: Life that no, that was actually Wayne's World.
- 24:10Speaker 8: Yeah, but that came for Saturnite Life.
- 24:12Speaker 1: Yeah, but maybe it was originally part of Saturday Alive
- 24:15Speaker 1: it was. Yeah, that's crazy how that stuff all comes
- 24:18Speaker 1: to me now we're officially old.
- 24:21Speaker 4: Yeah, I don't know if my students would get the
- 24:23Speaker 4: Wayne's World joke.
- 24:24Speaker 2: No, No, they won't, They absolutely won't. All right, why
- 24:30Speaker 2: why did this?
- 24:31Speaker 1: Why did this tweak your and and have your your
- 24:34Speaker 1: spider sense tingling?
- 24:36Speaker 8: Joey?
- 24:36Speaker 2: What was it the story that that got you going?
- 24:40Speaker 8: Yeah?
- 24:40Speaker 4: So thanks again for a lot of us to have
- 24:42Speaker 4: a conversation about it, because sometimes social media posts, you know,
- 24:45Speaker 4: you're trying to make up you know, you're trying to
- 24:47Speaker 4: get a point out there, and you know it turns
- 24:49Speaker 4: into any Actually, several folks that are involved with these
- 24:52Speaker 4: companies have reached out, you know, at least connected and
- 24:55Speaker 4: and and you know, I want to be clear that
- 24:56Speaker 4: I have nothing against any of these companies, these that
- 25:00Speaker 4: are that are pursuing this. Uh, you know, I don't.
- 25:04Speaker 4: I don't have any special connections to them or anything
- 25:07Speaker 4: like that. I've been I've been very concerned broadly about
- 25:11Speaker 4: where we're heading with how we advertise pharmaceuticals. Both drug
- 25:18Speaker 4: company or pharmacy or how pharmacies are involved.
- 25:21Speaker 3: Uh.
- 25:21Speaker 4: And I've been very active recently. We published a paper
- 25:24Speaker 4: in jama Health Forum on the marketing of these glp
- 25:28Speaker 4: ones and so specifically with this ad, you've got a
- 25:31Speaker 4: really cool meme, and I do like the meme. It's
- 25:34Speaker 4: a funny meme. Uh. And it's you know, essentially the
- 25:37Speaker 4: bigger guy looking at fella and looking away from the
- 25:40Speaker 4: high priced do zempic, right, So they are essentially marketing
- 25:44Speaker 4: their low price product. And then of course when you
- 25:47Speaker 4: really dive into what this fellow health is doing uh
- 25:50Speaker 4: and and you know it's a telehealth company, and then
- 25:52Speaker 4: they're working with a couple of pharmacy partners who are
- 25:56Speaker 4: providing compounded golp ones. And my my concern is like
- 26:01Speaker 4: we're having like mass production of compounded products that that
- 26:06Speaker 4: starts getting away from what you know, I believe compounding is,
- 26:10Speaker 4: and I'm very supportive of compounding phombacy. I absolutely love
- 26:14Speaker 4: compoundings as part of our profession. But we're in a
- 26:17Speaker 4: place here where it feels like we're creating generic drugs
- 26:21Speaker 4: and we're not following the same processes of other generic
- 26:25Speaker 4: drugs and it's it's creating a lot of things that
- 26:27Speaker 4: are making me uncomfortable. So I called it out. And
- 26:30Speaker 4: I know the folks at Strive Pharmacy have commented and
- 26:34Speaker 4: and fella have commented, so I know that they're they're
- 26:37Speaker 4: probably not too happy with me, but happy to talk
- 26:39Speaker 4: with them too, because I want them to be successful businesses.
- 26:43Speaker 4: I just want to like, I'm more concerned about the
- 26:45Speaker 4: overall policy, uh, and what we're doing for our supply chain.
- 26:49Speaker 1: Well, guess what, guys and listeners, we have a lawyer
- 26:52Speaker 1: on with us today and we're going to throw him
- 26:55Speaker 1: into the fire. And and you're not your your skin
- 26:58Speaker 1: is so thick, Darshan, and that you're ready for anything.
- 27:01Speaker 2: So what do you think about all this?
- 27:03Speaker 8: So let's let's start by the usual disclaimer. This is
- 27:06Speaker 8: not legal advice. Having said that, I've literally written the
- 27:10Speaker 8: book on clinical research and on advertising and on pharmacy.
- 27:14Speaker 8: I've actually helped some of the people here on it,
- 27:17Speaker 8: so I'm very very familiar with the space. To be clear,
- 27:21Speaker 8: your situation may be different. The general rule is that
- 27:27Speaker 8: the FDA, the Office of Drug Promotion OPDP, really stands
- 27:30Speaker 8: for comes in and basically says, look, we're going to
- 27:33Speaker 8: allow you to market a drug, you're going to have
- 27:37Speaker 8: to make sure that there's fair balance, for example, that
- 27:40Speaker 8: you're making claims that can be supported so to that
- 27:45Speaker 8: and failure to do that exposes companies to multi billion
- 27:48Speaker 8: dollar fines. And there are a range of different things
- 27:52Speaker 8: that come into that, but you could be looking at
- 27:54Speaker 8: multi billion dollar finds. GSK paid a three billion dollar
- 27:57Speaker 8: fine one point, not related direction to this, but the
- 28:01Speaker 8: idea being we don't want patients. And to be clear,
- 28:04Speaker 8: both Joey and I are pharmacists, so it's not like
- 28:06Speaker 8: I'm coming from a place of I don't want pharmacy
- 28:08Speaker 8: to succeed. I was a pharmacist, I am a pharmacist.
- 28:12Speaker 8: So I think compounding serves a huge role, but it
- 28:16Speaker 8: serves a role, and I think what we're now starting
- 28:18Speaker 8: returning to see is pharmacies trying to say we're more
- 28:21Speaker 8: than that. And that's what concerns me. Are we really
- 28:24Speaker 8: now operating the best interest of patients? There were supposed
- 28:29Speaker 8: to be about either addressing shortages or they were addressing
- 28:32Speaker 8: special needs, And my question is what are we doing
- 28:35Speaker 8: in that specific instance. If you pull up the ad,
- 28:38Speaker 8: you have right up there pharmacuool companies in general run
- 28:43Speaker 8: all of their ads through what's called a PRC committee,
- 28:46Speaker 8: a promotional review committee that you have a lawyer, you
- 28:49Speaker 8: have a regulatory person, and you have a medical person,
- 28:53Speaker 8: all reviewing any potential outgoing documentation to see does that
- 28:56Speaker 8: make sense? Is it reflective? In these specific situations, What
- 29:00Speaker 8: you land up with is someone saying why is how
- 29:03Speaker 8: is that claim supported? So to that end, you you
- 29:08Speaker 8: have a bigger guy claiming that fella is something that's
- 29:12Speaker 8: more attractive to him or her than ozempic. If that's true,
- 29:17Speaker 8: what is the basis of your superiority claim? Where's the
- 29:21Speaker 8: fair where's the fair balance?
- 29:23Speaker 3: Hm?
- 29:23Speaker 8: And that none of that exists. And to me, that's
- 29:26Speaker 8: what concerns me. You're you're seeing people make claims that
- 29:30Speaker 8: just you simply couldn't couldn't justify. The Supreme Court had
- 29:34Speaker 8: and a lot of compounding pharmacies. Go back to Western
- 29:37Speaker 8: States and try to say that's what gives me the
- 29:39Speaker 8: authority to advertise, Well, it doesn't. And and I would
- 29:43Speaker 8: argue that Western States was number one in the early
- 29:46Speaker 8: two thousands before five oh three and five or three
- 29:48Speaker 8: five or three A and five or three B pharmacies
- 29:49Speaker 8: came out. It was in a very specific time, time
- 29:52Speaker 8: and place. And since then First Amendment law has evolved.
- 29:56Speaker 8: You have you are seeing that you have to at
- 29:59Speaker 8: all times be true not misleading. My question to you,
- 30:02Speaker 8: and I'm not asking you the one of you to
- 30:04Speaker 8: answer this this is but is that truthful and not misleading?
- 30:09Speaker 8: And I'm sure I could get several people to argue
- 30:12Speaker 8: that it is. And that's my concern. I'm not saying
- 30:15Speaker 8: that this should be specifically targeted. The question is do
- 30:19Speaker 8: we need better oversight? And to that end, there are
- 30:22Speaker 8: a there are actual laws that are being considered specifically
- 30:28Speaker 8: to address this. The reason we have less enforcement around this,
- 30:32Speaker 8: and that's not to say no enforcement, there is enforcement.
- 30:35Speaker 8: The reason you're seeing less enforcement around this is because
- 30:38Speaker 8: the FDA's purview is a little unclear. The purview is
- 30:42Speaker 8: are they allowed to regulate drug advertising if it comes
- 30:45Speaker 8: from a compounding pharmacy. That's not to say that the
- 30:49Speaker 8: DJ couldn't do it. The DJ could absolutely get into it,
- 30:52Speaker 8: State board, the pharmacy can absolutely get into it. The
- 30:55Speaker 8: questions do they ad the expertise? You see someone being harmed,
- 30:58Speaker 8: that's when you're gonna see the problem. We saw this
- 31:00Speaker 8: with compounding pharmacies in general, compounding pharmacy. I remember taking
- 31:04Speaker 8: a course from University of Florida in two thousand and
- 31:06Speaker 8: eight with I Forget the Company, and they were great.
- 31:10Speaker 8: They taught me how to compound. But I remember going
- 31:14Speaker 8: things need to evolve. I can't believe some of the
- 31:16Speaker 8: claims I'm allowed to make. And then you saw the
- 31:20Speaker 8: big tragedy in twelve twenty thirteen, and that's what caused
- 31:24Speaker 8: five three a's and five or three beast to happen.
- 31:26Speaker 8: We're starting to see that same problem with some of
- 31:28Speaker 8: the advertisements. We've seen claims being made that are unsupported.
- 31:31Speaker 8: And that's the concern. That's the problem. I'll stop right there.
- 31:35Speaker 1: Well, that's the whole point of this post, Joey, is
- 31:38Speaker 1: your concern. And when you come at things, you always
- 31:42Speaker 1: give a balance approach, even though people jump on you
- 31:45Speaker 1: in Twitter and obviously on LinkedIn, and but I see
- 31:50Speaker 1: a balance of what you're trying to say. And back
- 31:52Speaker 1: to what dar Shawn's saying in protection of true compounders
- 31:56Speaker 1: and people out there who are diligent and who follow
- 31:59Speaker 1: the processes to the t.
- 32:01Speaker 8: And I know some great ones let's be clear that
- 32:03Speaker 8: there are some great combating pharms that do that, right, Yep, exactly, And.
- 32:07Speaker 4: I definitely don't want to say that the folks at
- 32:10Speaker 4: at either of these two companies, like they could be
- 32:12Speaker 4: doing it very well too, right, And so ultimately it's
- 32:17Speaker 4: like we we just have to recognize like like there
- 32:19Speaker 4: was a study that a large number of like, we've
- 32:22Speaker 4: got some bad actors in this space that are that
- 32:25Speaker 4: are taking advantage of people. There are people throwing up websites. Uh,
- 32:29Speaker 4: some aren't even delivering products. Some are delivering product and
- 32:32Speaker 4: it's a it's adulterated or it's not actually what it
- 32:34Speaker 4: says it is. And so you've got some bad actors
- 32:36Speaker 4: in the space, which you know, the Alliance for Pharmacy Compounding,
- 32:39Speaker 4: like Scott and his team that they've done a phenomenal
- 32:42Speaker 4: job trying to educate people on this, which is awesome, right,
- 32:45Speaker 4: Like I love that that that that they know that
- 32:48Speaker 4: this could harm legitimate compounding when there are bad actors,
- 32:53Speaker 4: so they are on it as well. I'm not saying
- 32:55Speaker 4: these guys are, I'm just saying that the way that
- 32:58Speaker 4: they're advertising, we you've got to be careful with what
- 33:01Speaker 4: what what's happening here? And ask like what you know?
- 33:05Speaker 4: Is this? Is this appropriate? Because also like, do you
- 33:08Speaker 4: do we think drug companies aren't watching this? Like do
- 33:10Speaker 4: we want drug advertisements? Do we want like the big
- 33:13Speaker 4: guys to start putting their money into ads? Like you know,
- 33:16Speaker 4: I criticized the Super Bowl ad that Hims and Hers
- 33:20Speaker 4: did a few weeks ago, and you know, I played
- 33:22Speaker 4: it in class and all my farm D students, like
- 33:25Speaker 4: several of them, like kind of gas are like like what?
- 33:28Speaker 4: And I was like, all right, so why are you
- 33:29Speaker 4: uncomfortable with the super Bowl lads? Like it's catchy, it's
- 33:31Speaker 4: kind of fun, it's kind of cool. Uh, but what's
- 33:34Speaker 4: what's the issue? Right? Like what's happening? And and if
- 33:36Speaker 4: my farm D students feel that, oh yeah, there's something
- 33:39Speaker 4: kind of wrong about this, then maybe it's time we
- 33:42Speaker 4: have a broader discussion. And look, I'm not saying it's
- 33:45Speaker 4: illegal either. Someone I think comment I think someone from
- 33:47Speaker 4: Strive on my post commented that what they're doing is
- 33:50Speaker 4: not illegal. I'm not saying it's not illegal.
- 33:52Speaker 8: It may not.
- 33:52Speaker 4: It may be perfectly legal, but that's not for me
- 33:55Speaker 4: to decide. I'm trying to say we need to have
- 33:57Speaker 4: this conversation and figure out like what should be a
- 34:00Speaker 4: appropriate and do we need updated laws? And Senator Durbin
- 34:04Speaker 4: and Marshall have introduced bipartisan legislation to try to bring
- 34:09Speaker 4: this this to discussion, so maybe it's time that we
- 34:11Speaker 4: do that.
- 34:12Speaker 8: I would also argue that the question of legal everything's legal.
- 34:17Speaker 8: It's sort of like lying on your taxes. Everything is
- 34:19Speaker 8: legal until you get caught, and that's the part you
- 34:23Speaker 8: have to be worried about. There there are some there
- 34:27Speaker 8: are some significant concerns with what was put out there
- 34:29Speaker 8: and the ad you just picked out. I'm not saying
- 34:31Speaker 8: that speaks to them overall. That's not even saying that
- 34:33Speaker 8: I'm commenting on that specific ad because I'm not their lawyer.
- 34:36Speaker 8: I'm not making a claim about it. But I would
- 34:39Speaker 8: probably have issues with that ad as it's put out
- 34:43Speaker 8: one person's discussion on without without being legal advice. And
- 34:47Speaker 8: I do review ads for a living, So there's that.
- 34:50Speaker 4: Out can I ask us all there, Sean, how do
- 34:52Speaker 4: you feel about the use of cost as a as
- 34:56Speaker 4: a use for compounding, because one of the issues that's
- 34:59Speaker 4: been coming up is that, and this early in my
- 35:01Speaker 4: career there were some times where I knew that a
- 35:06Speaker 4: compounded product could be more affordable for a patient for
- 35:10Speaker 4: various reasons versus the branded pret right. Yeah, And and
- 35:13Speaker 4: so I just want to be clear that I a
- 35:17Speaker 4: thousand percent empathize with any pharmacist and any patient that's
- 35:21Speaker 4: in a situation where, like, you know, if I can
- 35:25Speaker 4: get it compounded cheaper, I'm going to go that route.
- 35:27Speaker 4: Like I totally understand that. And that's a bigger issue
- 35:30Speaker 4: with like our insurance, the way our insurance has done,
- 35:33Speaker 4: the way our healthcare system is set up. But like
- 35:36Speaker 4: the way this is currently going, you're subverting patents. You know,
- 35:40Speaker 4: like you're saying, can I just compound this this brand
- 35:44Speaker 4: name drug and give it to you at two hundred
- 35:46Speaker 4: dollars a month? When you know what I mean? Like,
- 35:48Speaker 4: like is that that's a sneaky way around our patent system.
- 35:51Speaker 4: And I feel crazy uncomfortable about that.
- 35:54Speaker 8: So several different things. Number One, it's not a sneakywear
- 35:57Speaker 8: on the patent system, because the patent system is completely separate.
- 36:00Speaker 8: Can still be in violation of patents, So let's be
- 36:02Speaker 8: clear about that existing. Number Two, you could still violate
- 36:06Speaker 8: the only game in town is not the FDA. Contrary
- 36:09Speaker 8: to popular belief, you also have the FTC. You also
- 36:12Speaker 8: have state boards of pharmacy who could be looking at it.
- 36:14Speaker 8: And then if you add on to it. Now, in
- 36:16Speaker 8: this case it may not apply, but you often see
- 36:18Speaker 8: doctors who are doing similar advertisements. You could have the
- 36:20Speaker 8: State Board of Medicine that comes in as well. Then
- 36:23Speaker 8: to the question you were pointing out, I'm sorry, I
- 36:26Speaker 8: feel like I'm almost issue spotting. But the other piece
- 36:30Speaker 8: of it is you ask what do you think about
- 36:32Speaker 8: the use of money as the differentiating factor? This is
- 36:35Speaker 8: actually a settled question. The FDA has specifically gotten into it.
- 36:39Speaker 8: You use what's called the car standard, so health economics
- 36:42Speaker 8: claims are supported or have to be reviewed under the
- 36:45Speaker 8: car standard competent and reliable scientific evidence. What studies have
- 36:49Speaker 8: you done to prove that this is better? For example,
- 36:52Speaker 8: if you're saying that this, I think it was one
- 36:54Speaker 8: ninety nine versus twelve hundred dollars whatever, It doesn't really
- 36:57Speaker 8: matter in that specific situation. What factor you consider? Are
- 37:00Speaker 8: you just looking at cost price? Are you looking at
- 37:03Speaker 8: cost price plus nursing care? Are you looking at cost
- 37:05Speaker 8: price plus nursing care plus adverse events? What happened in
- 37:09Speaker 8: the case of admissibility. How many people were you looking at.
- 37:13Speaker 8: I'm not saying it's wrong. Obviously on his face it
- 37:15Speaker 8: may be completely accurate, but is it completely accurate? And
- 37:19Speaker 8: if you're just making a claim based on well, it's obvious,
- 37:22Speaker 8: isn't it, that does not satisfy a competent and reliable
- 37:25Speaker 8: signific evidence standard. Did answer the question, Joey.
- 37:31Speaker 4: Absolutely, I hadn't thought about yet. And again as the
- 37:34Speaker 4: when when you're not factoring in the cost of potential
- 37:36Speaker 4: adverse events, that's right, and you and you wonder why
- 37:39Speaker 4: pharmaceutical companies and again like they're not like I've not
- 37:43Speaker 4: seen and I want to maybe use Eli Lilly and
- 37:46Speaker 4: Novo in these groups. So they've been round and round
- 37:48Speaker 4: over insulin for twenty you know, I don't they typically
- 37:52Speaker 4: don't you know, Well, well, I guess now now that
- 37:54Speaker 4: they've got so ways for the audience as well if
- 37:57Speaker 4: they haven't seen the news. Eli Lilly has had their
- 38:00Speaker 4: Eli Lilly direct and then Novo Nordis just announced their
- 38:04Speaker 4: direct to consumer. Also also, Eli Lilly is partnering with
- 38:08Speaker 4: a company called Row, which is also an online tele
- 38:11Speaker 4: health company. So this is where we're headed. Uh, and
- 38:15Speaker 4: maybe the big pharmaceutical manufacturers are getting in this, and
- 38:18Speaker 4: and there's maybe if I could play devil's advocate, maybe
- 38:20Speaker 4: there's a positive, you know, the fact that these companies
- 38:23Speaker 4: are pushing the envelope. It maybe it's forcing the big
- 38:26Speaker 4: guys to to move as well. So maybe there's a
- 38:29Speaker 4: maybe there'sn't that benefit in this and that that it
- 38:31Speaker 4: forces these guys to lower their price and go direct
- 38:34Speaker 4: to consumer or do some other things.
- 38:36Speaker 8: I'm gonna I'm gonna add on to what you said there, Joey,
- 38:38Speaker 8: because the pricing that came out from both Novo and
- 38:41Speaker 8: from Lily was five hundred dollars, which I think is
- 38:45Speaker 8: amazing because the truth is, are you pulling it out? Yeah,
- 38:50Speaker 8: there you go. Yeah, and that's just Lily today. If
- 38:52Speaker 8: you pull up to day's well, yeah, today's news. Novo
- 38:56Speaker 8: put out his information and they're gonna charge about five
- 38:59Speaker 8: hundred bucks as well. Now, the average compounding pharmacies probably
- 39:01Speaker 8: in the two ninety nine to four ninety nine range,
- 39:05Speaker 8: so it's within range of what you're what you're talking about,
- 39:08Speaker 8: except it's being made in a manufacturing facility. Now, I
- 39:11Speaker 8: will argue that I've personally had. I've been using one
- 39:15Speaker 8: of these products for a while, So I'm a patient,
- 39:18Speaker 8: not speaking purely from just a pharmacist perpective or lawyer perspective.
- 39:22Speaker 8: I'm speaking for the patient perspective. So I one thousand
- 39:25Speaker 8: percent understand the idea of I need a drug because
- 39:29Speaker 8: it's addressing my liver, it's addressing my diabetes, it's addressing
- 39:33Speaker 8: my weightloth like, all of these are are important things.
- 39:36Speaker 8: So I'm a thousand percent in favor of having the
- 39:39Speaker 8: drug available and know, if you can't do it, that's
- 39:41Speaker 8: on you, lily. If you can't do it, that's on you.
- 39:44Speaker 8: And these pharmacies have forced these companies to literally go
- 39:49Speaker 8: all bets are off, We're going to invest in manufacturing
- 39:52Speaker 8: facilities and get these drugs online, and they did and allegedly,
- 39:57Speaker 8: and there's a whole lawsuit about this. The shortages are
- 39:59Speaker 8: as because I would argue because of these compounding facilities,
- 40:04Speaker 8: But that doesn't give us as pharmacists as lawyers free
- 40:10Speaker 8: reign to advertise a drug in a way that is
- 40:15Speaker 8: not completely consistent with the truthful and not misleading standard,
- 40:19Speaker 8: because the Supreme Court has always said that that's the standard,
- 40:22Speaker 8: So I'm pretty sure you couldn't meet that standard with
- 40:25Speaker 8: what was put out there.
- 40:30Speaker 1: This is interesting and the headline at USA today is
- 40:34Speaker 1: WI GOVI price cut. Nova Nordis cuts the price of
- 40:37Speaker 1: the weight loss drug for the uninsured. And I mean
- 40:42Speaker 1: it's I saw just go.
- 40:45Speaker 8: Down to see what the price was though, so just
- 40:47Speaker 8: so people can see it.
- 40:48Speaker 2: Where is the price?
- 40:49Speaker 8: I think there should be one there? You go for
- 40:51Speaker 8: nine nine per month.
- 40:54Speaker 2: Yep, Nova Care.
- 40:57Speaker 8: What I think is interesting and I knowed, Uh, Todd
- 40:59Speaker 8: Gregg have to have a different discussion about this, whether
- 41:01Speaker 8: we're talking about Row, whether we're talking about Novo Care
- 41:04Speaker 8: or Lily Direct. Are they going to eliminate pharmacies because
- 41:10Speaker 8: they starting to start seeing this antagonistic relationship. M Well,
- 41:15Speaker 8: and that worries me. God, Jake, Yeah, I was just.
- 41:18Speaker 4: Gonna comment like, uh, you know, one of the issues
- 41:20Speaker 4: we run into when we think about shortage of these
- 41:23Speaker 4: products is sometimes is it is it related to the
- 41:25Speaker 4: shortage at the manufacturer level or are there pharmacies not
- 41:28Speaker 4: stocking these products because of their reimbursement rates that actually,
- 41:32Speaker 4: I believe that is true in a lot of cases.
- 41:34Speaker 4: I think if if you have some pharmacies looking at
- 41:38Speaker 4: losing money on dispensing these It's crazy. That's crazy to
- 41:42Speaker 4: me that that that that that could be happening, and
- 41:45Speaker 4: that's likely what we could run into here. So like
- 41:48Speaker 4: we need to have a bigger conversation because like right now,
- 41:51Speaker 4: pharmacies are probably watching and seeing like, well, what's going
- 41:54Speaker 4: on these telehealth companies and are partnering. And then there's
- 41:56Speaker 4: you know, and and you can't just go to your
- 42:00Speaker 4: local Walgreens or your local or any other far your
- 42:03Speaker 4: independent pharmacy. It doesn't have a contract you know with
- 42:06Speaker 4: this kind of thing. Uh, And then they you know,
- 42:08Speaker 4: they try to take the patient's insurance whether or not
- 42:11Speaker 4: if the patient's insurance actually covers it, then they still
- 42:14Speaker 4: but they might you know, lose money on their AWP
- 42:16Speaker 4: based arrangement.
- 42:19Speaker 1: YEP, I really appreciate this your insights, both of you.
- 42:24Speaker 1: Definitely want to have you back on another this week
- 42:27Speaker 1: in pharmacy, we can dig deeper if you're listening and
- 42:30Speaker 1: you want to reach out to either of these pharmacy mavericks.
- 42:37Speaker 1: Reach out to Joey Maddingly on LinkedIn or Darshawn Carnie
- 42:42Speaker 1: on LinkedIn. I can't wait for your next discussion. Darshawn,
- 42:46Speaker 1: you do a ton of linked lives and I enjoy those,
- 42:49Speaker 1: So you have to promise to come back and the
- 42:52Speaker 1: three of us can what do they call this squabble
- 42:55Speaker 1: budding or.
- 42:58Speaker 2: Pobble talking or whatever we're doing?
- 43:01Speaker 8: Is that a thing I've now learned to new words
- 43:03Speaker 8: squabble budding and pobble talking talking.
- 43:07Speaker 1: It's the kids language, it's the it's the riz out there,
- 43:10Speaker 1: it's the skibbity.
- 43:11Speaker 2: I'm trying to I'm trying to learn the new words.
- 43:15Speaker 2: I'm not doing a good job in it.
- 43:16Speaker 8: I'm going to talk with you later. Todd's right, it's
- 43:21Speaker 8: an honor.
- 43:21Speaker 1: Thanks Todd, Thank you, welcome, thank you well here what
- 43:25Speaker 1: We'll talk to you next time on.
- 43:27Speaker 2: Tworksh that was fun.
- 43:35Speaker 1: That was fun to be able to really dive in
- 43:38Speaker 1: and talk with dar Sean and Joey Maddingly. That's exciting
- 43:44Speaker 1: for us to be able to get news to you
- 43:47Speaker 1: coming out as quickly as possible. We want you to
- 43:50Speaker 1: get involved. If you have something that you want to
- 43:52Speaker 1: share on a future this week in pharmacy, please reach
- 43:55Speaker 1: out to me. I'm on LinkedIn, easy to find at
- 43:58Speaker 1: pharmacy podcast on any of the social media platforms. We
- 44:02Speaker 1: will be attending the APHA, the American Pharmacists Association twenty
- 44:06Speaker 1: twenty five event. It's going to be in Nashville, Tennessee.
- 44:12Speaker 1: If you are attending, make sure that you come to
- 44:15Speaker 1: our press booth. We will be in booth one two five,
- 44:19Speaker 1: that's one hundred and twenty five. And we are thrilled
- 44:24Speaker 1: to be working with Route RX four. Route and it's
- 44:29Speaker 1: a logistics company that's going to be talking about outsource
- 44:32Speaker 1: staffing and how you can leverage outsource talented staffing that
- 44:37Speaker 1: understands your business and understands the business of pharmacy to
- 44:41Speaker 1: expand your team without paying a full price for a
- 44:46Speaker 1: full time employee. It's a really interesting model. Cannot wait
- 44:51Speaker 1: to share more about this on this Week in Pharmacy.
- 44:55Speaker 1: I hope you have a great week. Please reach out,
- 44:57Speaker 1: Please subscribe to the show. Please share works because we're
- 45:01Speaker 1: works in for you. That's just not a thing. I
- 45:04Speaker 1: have to come up with a with a good tagline
- 45:06Speaker 1: for Torques this Week in Pharmacy.
- 45:09Speaker 2: We'll talk to you next time.